DJO Global

Enable Injections Enhances Board with Addition of Vickie Capps

Retrieved on: 
Tuesday, November 7, 2023

CINCINNATI, Nov. 7, 2023 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of wearable drug delivery systems, is pleased to announce the appointment of Vickie Capps to the company's Board of Directors as the head of the audit committee.

Key Points: 
  • New director, Vickie Capps, brings comprehensive financial expertise and leadership experience to Enable Injections, serving as head of the audit committee.
  • CINCINNATI, Nov. 7, 2023 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of wearable drug delivery systems, is pleased to announce the appointment of Vickie Capps to the company's Board of Directors as the head of the audit committee.
  • New board director, Vickie Capps, brings comprehensive financial and leadership experience to Enable Injections.
  • "Vickie brings a wealth of experience and financial acumen to our Board at a pivotal stage for Enable Injections," said Mike Hooven, Chairman and CEO of Enable Injections.

Conventus Flower Orthopedics Announces Jeff Culhane as Chief Operating Officer

Retrieved on: 
Monday, March 27, 2023

HORSHAM, Pa., March 27, 2023 /PRNewswire/ -- Conventus Flower Orthopedics, an innovation-driven medical technology company, announced that Jeff Culhane has joined the organization as the Chief Operating Officer (COO), effective immediately.

Key Points: 
  • HORSHAM, Pa., March 27, 2023 /PRNewswire/ -- Conventus Flower Orthopedics, an innovation-driven medical technology company, announced that Jeff Culhane has joined the organization as the Chief Operating Officer (COO), effective immediately.
  • With expertise in product development, process innovation, and operations, Culhane most recently served as Chief Product Officer for Precision Medical, Inc.
  • Prior to that, Culhane led the new product development as Vice President of Research and Development for DJO Global.
  • "I am thrilled to join the Conventus Flower Orthopedics team," said Culhane.

FORMER LUCIRA EVP & CQO JOINS IDENTIFYSENSORS AS EVP & CHIEF QUALITY OFFICER

Retrieved on: 
Tuesday, February 21, 2023

CLEVELAND, Feb. 21, 2023 /PRNewswire/ -- IdentifySensors® Biologics, the leading developer of digital diagnostic technologies, has named industry veteran Ghazi Kashmolah executive vice president regulatory affairs and chief quality officer. Kashmolah joins the company from Lucira Health, where he served as chief quality officer and executive vice president regulatory affairs.

Key Points: 
  • CLEVELAND, Feb. 21, 2023 /PRNewswire/ -- IdentifySensors® Biologics, the leading developer of digital diagnostic technologies, has named industry veteran Ghazi Kashmolah executive vice president regulatory affairs and chief quality officer.
  • Kashmolah joins the company from Lucira Health, where he served as chief quality officer and executive vice president regulatory affairs.
  • The company's initial product, Check4®, is a diagnostics platform that digitally detects infections through graphene-based biosensors within five minutes.
  • The technology has been incorporated into a portable Bluetooth device for rapid results of multiple pathogens.

CraniUS Appoints Industry-Leading Executive in MedTech Space to serve as Vice-Chair on Board of Directors

Retrieved on: 
Tuesday, February 7, 2023

Ms. Wolfington brings nearly four decades of medical device leadership amongst numerous global companies including Stryker, DJO Global, and Acumed.

Key Points: 
  • Ms. Wolfington brings nearly four decades of medical device leadership amongst numerous global companies including Stryker, DJO Global, and Acumed.
  • Most recently, Sharon served as the President and CEO at Acumed (a subsidiary of Colson Associates, a spinoff of the Marmon Group, a Berkshire Hathaway company).
  • "CraniUS is delighted to have Sharon joining our Board of Directors as Vice-Chair," said Michael Maglin, CEO of CraniUS.
  • "Without question, she is one of the most respected MedTech leaders and a true innovator in the medical device space.

MachineMetrics Continues To Lead Medical Manufacturing's Digital Transformation, Wins Global Contract with Paragon Medical

Retrieved on: 
Tuesday, December 6, 2022

As a world leader in Med Tech, Paragon constantly strives to differentiate in ways that matter to our clients," said Matt Hanks, Chief Operating Officer for Paragon.

Key Points: 
  • As a world leader in Med Tech, Paragon constantly strives to differentiate in ways that matter to our clients," said Matt Hanks, Chief Operating Officer for Paragon.
  • "Our value capture from the MachineMetrics solution has been outstanding and we look forward to a long and successful partnership with the MachineMetrics team."
  • We're proud to support their organization as they continue to lead this industry's digital transformation."
  • The deal with Paragon Medical is the latest in what has been a record-breaking year of growth for MachineMetrics.

Virgin Galactic Appoints Sarah E. Kim as EVP, Chief Legal Officer

Retrieved on: 
Monday, November 21, 2022

Virgin Galactic Holdings, Inc. (NYSE: SPCE) (the Company or Virgin Galactic), an aerospace and space travel company, today announced that Sarah E. Kim will join the Company as Executive Vice President, Chief Legal Officer and Corporate Secretary, effective on December 5, 2022.

Key Points: 
  • Virgin Galactic Holdings, Inc. (NYSE: SPCE) (the Company or Virgin Galactic), an aerospace and space travel company, today announced that Sarah E. Kim will join the Company as Executive Vice President, Chief Legal Officer and Corporate Secretary, effective on December 5, 2022.
  • I am thrilled to welcome Sarah to the Virgin Galactic team.
  • Sarahs experience in innovative and high growth companies will greatly benefit Virgin Galactic as we advance toward the launch of commercial service and continue to grow, said Michael Colglazier, CEO of Virgin Galactic.
  • Kim joins Virgin Galactic from Topgolf Callaway Brands Corp. (Topgolf Callaway), where she served as General Counsel, Corporate Secretary, Chief Ethics Officer and Compliance Officer during a period of intense growth across the company.

Bone Growth Stimulator Market is expected to generate a revenue of USD 1.66 Billion by 2028, Globally, at 6.08% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, November 8, 2022

JERSEY CITY, N.J., Nov. 8, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Bone Growth Stimulator Market" By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries), By Geographic Scope And Forecast.

Key Points: 
  • JERSEY CITY, N.J., Nov. 8, 2022 /PRNewswire/ --Verified Market Research recently published a report, " Bone Growth Stimulator Market " By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries), By Geographic Scope And Forecast.
  • As per the deep research carried out by Verified Market Research, the global Bone Growth Stimulator Market size was valued at USD 1.04 Billion in 2020 and is projected to reach USD 1.66 Billion by 2028, growing at a CAGR of 6.08% from 2021 to 2028.
  • The Bone Growth Stimulator therapy is recommended by the physicians to help after a fracture or spinal fusion surgery to help the fractures repair more quickly.
  • Verified Market Research has segmented the Global Bone Growth Stimulator Market On the basis of Product, Application, and Geography.

Bone Growth Stimulator Market is expected to generate a revenue of USD 1.66 Billion by 2028, Globally, at 6.08% CAGR: Verified Market Research®

Retrieved on: 
Tuesday, November 8, 2022

JERSEY CITY, N.J., Nov. 8, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Bone Growth Stimulator Market" By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries), By Geographic Scope And Forecast.

Key Points: 
  • JERSEY CITY, N.J., Nov. 8, 2022 /PRNewswire/ --Verified Market Research recently published a report, " Bone Growth Stimulator Market " By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries), By Geographic Scope And Forecast.
  • As per the deep research carried out by Verified Market Research, the global Bone Growth Stimulator Market size was valued at USD 1.04 Billion in 2020 and is projected to reach USD 1.66 Billion by 2028, growing at a CAGR of 6.08% from 2021 to 2028.
  • The Bone Growth Stimulator therapy is recommended by the physicians to help after a fracture or spinal fusion surgery to help the fractures repair more quickly.
  • Verified Market Research has segmented the Global Bone Growth Stimulator Market On the basis of Product, Application, and Geography.

OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 6, 2022

Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.

Key Points: 
  • Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.
  • The knee braces and supports segment had the major share of the OTC braces and supports Market, by product, in 2021"
    Based on product, the OTC braces and supports market is divided into knee, ankle; back, hip, & spine; foot walkers and orthoses; hand & wrist; shoulder; elbow; and facial braces and supports.
  • In 2021, preventive care segment accounted for the largest share in the market, by application"
    Based on the application, the OTC braces and supports market is segmented into preventive care, ligament injury, osteoarthritis, compression therapy, and other applications.
  • The global otc braces and supports market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, October 6, 2022

Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.

Key Points: 
  • Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.
  • The knee braces and supports segment had the major share of the OTC braces and supports Market, by product, in 2021"
    Based on product, the OTC braces and supports market is divided into knee, ankle; back, hip, & spine; foot walkers and orthoses; hand & wrist; shoulder; elbow; and facial braces and supports.
  • In 2021, preventive care segment accounted for the largest share in the market, by application"
    Based on the application, the OTC braces and supports market is segmented into preventive care, ligament injury, osteoarthritis, compression therapy, and other applications.
  • The global otc braces and supports market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.